Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,541
Closed -$633K 92
2023
Q3
$633K Sell
6,541
-656
-9% -$68.9K 0.63% 83
2023
Q2
$785K Sell
7,197
-216
-3% -$23K 0.7% 77
2023
Q1
$734K Sell
7,413
-150
-2% -$15.8K 0.67% 81
2022
Q4
$830K Buy
7,563
+850
+13% +$88K 0.82% 59
2022
Q3
$650K Sell
6,713
-1,309
-16% -$140K 0.54% 83
2022
Q2
$872K Sell
8,022
-1,344
-14% -$153K 0.61% 77
2022
Q1
$1.11M Buy
9,366
+140
+2% +$17.4K 0.49% 89
2021
Q4
$1.3M Buy
+9,226
New +$1.18M 0.47% 80

Other funds holding ABT

SRN Advisors's ABT Position: Q4 2023 in Review

SRN Advisors sold out of Abbott (ABT) in Q4 2023, closing a stake of 6,541 shares — an estimated $633K sold.

SRN Advisors first reported a position in ABT in Q4 2021 and held it in 8 quarters. The position peaked at $1.3M in Q4 2021. 2,886 funds tracked by Wall St. Rank hold ABT as of Q4 2023.

  • SRN Advisors reported no remaining Abbott position as of Q4 2023 after selling out during the quarter.
  • SRN Advisors sold 6,541 Abbott shares in Q4 2023, an estimated $633K.
  • SRN Advisors first reported a position in Abbott in Q4 2021 and held it in 8 quarters.
  • SRN Advisors's Abbott position peaked at $1.3M in Q4 2021.
  • 2,886 funds tracked by Wall St. Rank held Abbott as of Q4 2023.

Based on SRN Advisors's 13F filing for Q4 2023, filed 14 Jun 2024.